Advertisement

Topics

Amarillo Biosciences Incorporated Company Profile

04:31 EDT 19th March 2019 | BioPortfolio

Amarillo Biosciences, Inc., (ABI), is a biopharmaceutical company developing low-dose oral and topical interferon alpha. We are directing our research at the treatment of Behcet's Disease, and oral warts in HIV+ patients and chronic cough in idiopathic pulmonary fibrosis. Low-dose oral interferon is Fundamentally Different from high dose injectable interferon. In this site, we will show the fundamental differences, and how we are pressing forward with our clinical trial programs, continued research and market development.The distinct advantages and characteristics of our product and part of the fundamental differences are it's oral delivery, and safety because of the low dose. Our product dose is only 1/20,000 (one twenty thousandth) of the typical injectable dose. We are committed to bringing low-dose oral interferon and it's many distinct advantages to a worldwide marketplace. "Good ideas are not adopted automatically. They must be driven into practice with courageous patience."

Location

4134 Business Park Drive Amarillo
Amarillo
79110
United States of America

Contact

Phone: 806-376-1741
Fax: 806-376-9301
Email: abi@amarbio.com


News Articles [622 Associated News Articles listed on BioPortfolio]

Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion

Illumina, Inc. and Pacific Biosciences announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction....

AUM Biosciences looks to advance anti-cancer molecule to Phase 2 later this year

AUM Biosciences CEO Vishal Doshi sat down with Proactive Investors at the BIO CEO and Investor Conference in New York. AUM Biosciences is a Singapore-based oncology-focused biotech company.

Life Biosciences LLC leads strategic investment in Prana

(Life Biosciences) Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) ('Prana' or 'the Company') has today announced that it has entered into a securities purchase agreement for a lead investment by Bos...

Illumina To Acquire Pacific Biosciences At $8.00/shr

SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN) and Pacific Biosciences (PACB) announced an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in a...

Caladrius Biosciences, Inc.: Caladrius Biosciences announces Purchase Agreement with Lincoln Park Capital for up to $26 million

BASKING RIDGE, NJ / ACCESSWIRE / March 14, 2019 / Caladrius Biosciences, Inc. (NASDAQ: CLBS) ('Caladrius' or the 'Company'), a late-stage therapeutics development biopharmaceutical company committe...

Caladrius Biosciences, Inc.: Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results

Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, NJ / ACCESSWIRE / March 14, 2019 / Caladrius Biosciences, Inc. (NASDAQ: CLBS) ("Caladrius" or the "Company"), a late-stage ther...

Tosoh Boosts Biosciences with Semba Buy

Japan’s Tosoh has strengthened and expanded its bioscience business following the acquisition of a 33.3% stake in Semba Biosciences. Financial details were not disclosed. Headquartered in Madiso...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Strategic Advisory Board

Kuros Biosciences appoints Strategic Advisory Board Schlieren (Zurich), Switzerland, September 25, 2018 - Kuros Biosciences (SIX: KURN) today announced the formation of its Strategic Advisory Boar...

Drugs and Medications [39 Associated Drugs and Medications listed on BioPortfolio]

Gelato topical anesthetic [mycone dental supply co., inc dba keystone industries and deepak products inc.]

NA

Eptifibatide [amneal biosciences]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION . EPTIFIBATIDE injection,...

Natelle one [meda pharmaceuticals]

natelleONE

Urea [exact-rx, inc.]

Urea Nail Gel 45% (in a vehicle containing camphor, menthol and eucalyptus oil) Rx Only

Isoproterenol hydrochloride [amneal biosciences llc]

Isoproterenol Hydrochloride Injection, USP Rx only Sterile Injection

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy

Venn Biosciences Corporation ("InterVenn") has developed a liquid biopsy that is capable of distinguishing benign from malignant masses in women presenting with adnexal (pelvic) masses, th...

Companies [416 Associated Companies listed on BioPortfolio]

Amarillo Biosciences, Inc.

Amarillo Biosciences Incorporated

Amarillo Biosciences, Inc., (ABI), is a biopharmaceutical company developing low-dose oral and topical interferon alpha. We are directing our research at the treatment of Behcet's Disease, and oral wa...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Amarillo Biosciences Incorporated" on BioPortfolio

We have published hundreds of Amarillo Biosciences Incorporated news stories on BioPortfolio along with dozens of Amarillo Biosciences Incorporated Clinical Trials and PubMed Articles about Amarillo Biosciences Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amarillo Biosciences Incorporated Companies in our database. You can also find out about relevant Amarillo Biosciences Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record